DREADD2.0: AN ENHANCED CHEMOGENETIC TOOLKIT
DREADD2.0: AN ENHANCED CHEMOGENETIC TOOLKIT
批准号:
8935928
负责人:
Jian Jin
金额:
$90.89万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-26 至 2017-05-31
关键词:
AdoptedAnimalsBRAIN initiativeBrainChemicalsCommunitiesDesigner DrugsDiagnosisDiseaseDown-RegulationDrosophila genusDrug KineticsEngineeringEquipmentEukaryotaG-Protein-Coupled ReceptorsGenerationsGoalsGrantGraphHealthIon ChannelIvermectinLigandsLongitudinal StudiesMethodsNeuronsNeurosciencesOpsinPathway interactionsPharmacodynamicsPrimatesPrincipal InvestigatorProcessPropertyPublicationsResearch PersonnelSignal PathwaySignal TransductionSynapsesTechniquesTechnologyTranslatingViralanalogbasebrain researchcell typedesensitizationimprovedinnovationmillisecondneuronal circuitryneuropsychiatryneurotechnologyneurotransmissionnovelnovel strategiesoptogeneticsprogramsreceptorrecombinasespatiotemporaltool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative has the ambitious goal of elucidating how neuronal ensembles interactively encode higher brain processes. To accomplish this goal, new and improved methods for both recording and manipulating neuronal activity will be needed. In this application, we focus on technologies for manipulating neuronal activity. The major significance of this application is that we will provide an enhanced chemogenetic toolbox that allows non-invasive, multiplexed spatiotemporal control of neuronal activity in domains ranging from single synapses to ensembles of neurons. To achieve this, we will provide: Chemical actuators with improved pharmacokinetics and pharmacodyamics suited for use with current DREADDs in eukaryotes ranging from Drosophila to primates (Specific Aim #1) Photo-caged CNO and other chemical actuators to provide millisecond-scale control (Specific Aim #1) Novel DREADDs and 'split-DREADDs' targeted to distinct neuronal pathways to enable multiplexed interrogation of neuronal circuits (Specific Aims #2 and 3) Chemogenetic platforms with minimized desensitization and down-regulation (Specific Aim #3)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Inhibitors of Lysine Methyltransferases G9a and GLP for the Treatment of Alzheimer's Disease
-
批准号:10752812
-
项目类别:
-
资助金额:$67.85万
-
财政年份:2023
-
负责人:Jian Jin
-
依托单位:
Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in cancer
-
批准号:10544005
-
项目类别:
-
资助金额:$47.93万
-
财政年份:2022
-
负责人:Jian Jin
-
依托单位:
Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in cancer
-
批准号:10389877
-
项目类别:
-
资助金额:$64.4万
-
财政年份:2022
-
负责人:Jian Jin
-
依托单位:
Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in caner
-
批准号:10908135
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2022
-
负责人:Jian Jin
-
依托单位:
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
-
批准号:10712396
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2022
-
负责人:Jian Jin
-
依托单位:
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
-
批准号:10387368
-
项目类别:
-
资助金额:$67.16万
-
财政年份:2022
-
负责人:Jian Jin
-
依托单位:
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
-
批准号:10615610
-
项目类别:
-
资助金额:$64.13万
-
财政年份:2022
-
负责人:Jian Jin
-
依托单位:
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
-
批准号:10745902
-
项目类别:
-
资助金额:$9.7万
-
财政年份:2022
-
负责人:Jian Jin
-
依托单位:
Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias
-
批准号:10222062
-
项目类别:
-
资助金额:$53.17万
-
财政年份:2021
-
负责人:Jian Jin
-
依托单位:
Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias
-
批准号:10372195
-
项目类别:
-
资助金额:$50.35万
-
财政年份:2021
-
负责人:Jian Jin
-
依托单位:
Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias
-
批准号:10616478
-
项目类别:
-
资助金额:$50.31万
-
财政年份:2021
-
负责人:Jian Jin
-
依托单位:
(PQ9) Developing EZH2 Degraders for Treating Triple-Negative Breast Cancer
-
批准号:10524118
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2018
-
负责人:Jian Jin
-
依托单位:
(PQ9) Developing EZH2 Degraders for Treating Triple-Negative Breast Cancer
-
批准号:10461023
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2018
-
负责人:Jian Jin
-
依托单位:
(PQ9) Developing EZH2 Degraders for Treating Triple-Negative Breast Cancer
-
批准号:10411409
-
项目类别:
-
资助金额:$8.91万
-
财政年份:2018
-
负责人:Jian Jin
-
依托单位:
(PQ9) Developing EZH2 Degraders for Treating Triple-Negative Breast Cancer
-
批准号:10227090
-
项目类别:
-
资助金额:$24.98万
-
财政年份:2018
-
负责人:Jian Jin
-
依托单位:
Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
-
批准号:10165660
-
项目类别:
-
资助金额:$53.24万
-
财政年份:2017
-
负责人:Jian Jin
-
依托单位:
Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
-
批准号:10282388
-
项目类别:
-
资助金额:$2.74万
-
财政年份:2017
-
负责人:Jian Jin
-
依托单位:
Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
-
批准号:10388676
-
项目类别:
-
资助金额:$8.9万
-
财政年份:2017
-
负责人:Jian Jin
-
依托单位:
Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
-
批准号:9362733
-
项目类别:
-
资助金额:$54.97万
-
财政年份:2017
-
负责人:Jian Jin
-
依托单位:
DREADD2.0: AN ENHANCED CHEMOGENETIC TOOLKIT
-
批准号:8819319
-
项目类别:
-
资助金额:$99.74万
-
财政年份:2014
-
负责人:Jian Jin
-
依托单位:
海外基金